Tag: whole-cell vaccine

BriaCell Therapeutics Shares Business Update

BriaCell Therapeutics provided an update on its collaborative and internal research as well as manufacturing activities.

BriaCell Closes CEO Equity Investment

BriaCell Therapeutics (TSXV:BCT, OTCQB:BCTXF) completed a non-brokered private placement financing of 5,612,083 units, totaling $1,346,900. As quoted in the press release: Under the...

BriaCell Approved by FDA for BriaVax Testing

BriaCell Therapeutics (TSX VENTURE:BCT) (OTCQB:BCTXF) has been cleared by the FDA to begin an open-label Phase I/IIa trial of its...